These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1636017)

  • 1. Radiocholesterol scintigraphy in Cushing's syndrome.
    Rufini V; Saletnich I; Troncone L
    Rays; 1992; 17(1):40-8. PubMed ID: 1636017
    [No Abstract]   [Full Text] [Related]  

  • 2. Adrenocortical scintigraphy.
    Troncone L; Danza FM
    Rays; 1992; 17(1):34-9. PubMed ID: 1636016
    [No Abstract]   [Full Text] [Related]  

  • 3. A black adrenocortical adenoma causing Cushing's syndrome not imaged by radiocholesterol scintigraphy.
    Reschini E; Baldini M; Cantalamessa L
    Eur J Nucl Med; 1990; 17(3-4):185-7. PubMed ID: 2279500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnosis of Cushing's syndrome using 131I-19-iodocholesterol uptake and adrenal imaging.
    Ortega D; Foz M; Doménech-Torné FM; Tresánchez JM
    Clin Endocrinol (Oxf); 1980 Aug; 13(2):145-9. PubMed ID: 7438469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical experience with the adrenal scanning agents iodine 131-19-iodocholesterol and selenium 75-6-selenomethylcholesterol.
    Reschini E; Catania A
    Eur J Nucl Med; 1991; 18(10):817-23. PubMed ID: 1743205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical values of adrenal scintigraphy by I-6-beta-iodomethyl-19-norcholesterol (123I-NCL) (author's transl)].
    Tateno Y; Shishido F; Kamoi I; Matsuura K; Takagi Y; Hashimoto S; Hotta T; Arimizu N; Fukushi K; Irie T; Ido T; Kojima M; Maeda M; Ogawa H; Itoh T
    Kaku Igaku; 1982 Mar; 19(2):245-53. PubMed ID: 7109324
    [No Abstract]   [Full Text] [Related]  

  • 7. Atlas of iodocholesterol scintigraphy (NP-59) in Cushing's syndrome with CT and MR correlation.
    Yu KC; Fraker DL; Ziessman HA
    Clin Nucl Med; 1996 Feb; 21(2):136-41. PubMed ID: 8697685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging the adrenal cortex: why and wherefore?
    Britton KE
    Nucl Med Commun; 1992 Jul; 13(7):485-7. PubMed ID: 1495676
    [No Abstract]   [Full Text] [Related]  

  • 9. 131I-iodocholesterol (NP-59) scintigraphy in adrenocortical diseases.
    Taillefer R; Soucy JP; Eybalin MC; Levasseur A
    J Can Assoc Radiol; 1983 Jun; 34(2):120-4. PubMed ID: 6885882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adrenocortical scintigraphy with 131I-19-iodocholesterol. Indications and results in 66 cases of hypercortisolism and hyperaldosteronism (author's transl)].
    Leger FA; Requeda E; Reach G; Plouin PF; Savoie JC
    Nouv Presse Med; 1981 Feb; 10(6):395-9. PubMed ID: 7220332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nuclear medicine methods for the diagnosis of adrenal tumors].
    Gregianin M; Bui F; Varotto L; Zucchetta P; Macri C
    Minerva Endocrinol; 1995 Mar; 20(1):27-38. PubMed ID: 7651280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenal localization in the adrenocorticotropic hormone-independent Cushing syndrome.
    Fig LM; Gross MD; Shapiro B; Ehrmann DA; Freitas JE; Schteingart DE; Glazer GM; Francis IR
    Ann Intern Med; 1988 Oct; 109(7):547-53. PubMed ID: 3421563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Improvement in the quality of 19-iodocholesterol-131I scintigraphy by using polysponin].
    Slavnov VN; Valueva GV; Markov VV; Luchitskiĭ EV; Iakovlev AA
    Med Radiol (Mosk); 1980 Sep; 25(9):14-8. PubMed ID: 7421434
    [No Abstract]   [Full Text] [Related]  

  • 14. [Adrenal gland scintigraphy].
    Fischer M; Vetter H
    Radiologe; 1986 Apr; 26(4):181-5. PubMed ID: 3012627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adrenal scanning using 19-iodocholesterol-I131].
    Slavnov VN; Valueva GV; Luchitskiĭ EV; Markov VV; Iakovlev AA
    Vrach Delo; 1979 Jul; (7):32-5. PubMed ID: 473741
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of preoperative iodocholesterol scintiscanning in patients undergoing adrenalectomy for Cushing's syndrome.
    Yu KC; Alexander HR; Ziessman HA; Norton JA; Doppman JL; Buell JF; Nieman LK; Cutler GB; Chrousos GP; Fraker DL
    Surgery; 1995 Dec; 118(6):981-6; discussion 986-7. PubMed ID: 7491543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenal scintigraphy with 131I-19-iodochlesterol in the diagnosis of Cushing's syndrome associated with adrenal tumor.
    Barliev GB
    Eur J Nucl Med; 1979 Dec; 4(6):449-51. PubMed ID: 520360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary aldosteronism and hyperandrogenism.
    Macrì C; Gregianin M; Bui F
    Rays; 1992; 17(1):49-61. PubMed ID: 1636018
    [No Abstract]   [Full Text] [Related]  

  • 19. The relationship of serum lipids to adrenal-gland uptake of 6 beta-[131I]iodomethyl-19-norcholesterol in Cushing's syndrome.
    Valk TW; Gross MD; Freitas JE; Swanson DP; Schteingart DE; Beierwaltes WH
    J Nucl Med; 1980 Nov; 21(11):1069-72. PubMed ID: 7431105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenal scintigraphy with 75Se selenonorcholestenol: a review.
    Sudell CJ; Blake GM; Gossage AA; Cullen DR; Munro DS
    Nucl Med Commun; 1985 Sep; 6(9):519-27. PubMed ID: 4069475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.